SCHEMBL28234613

SCHEMBL28234613

CSc1cc2c3c(ccc2c2ccccc12)CCCC3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 2/20 0.43
▸ NPC1 O15118 1/20 0.35
▸ CDK4 P11802 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ BCL2L1 Q07817 1/20 0.33
▸ BAD Q92934 1/20 0.33
▸ STAT3 P40763 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HTR3E A5X5Y0 1/20 0.33
▸ HTR3B O95264 1/20 0.33
▸ HTR3A P46098 1/20 0.33
▸ HTR3D Q70Z44 1/20 0.33
▸ HTR3C Q8WXA8 1/20 0.33
▸ ADORA2A P29274 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ NQO1 P15559 3/20 0.31
▸ GRIA1 P42261 1/20 0.31
▸ GRIA2 P42262 1/20 0.31
▸ GRIA3 P42263 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27288088 0.80 KIF11 (0.47) KIF11CDK4CCND1BCL2L1BAD
SCHEMBL27632129 0.75 KIF11 (0.46) KIF11CDK4CCND1BCL2L1BAD
SCHEMBL27466975 0.75 KIF11 (0.46) KIF11CDK4CCND1BCL2L1BAD
SCHEMBL27430162 0.75 KIF11 (0.46) KIF11CDK4CCND1BCL2L1BAD
SCHEMBL30662035 0.75 BCL2L1 (0.48) KIF11CDK4CCND1BCL2L1BAD
SCHEMBL27772008 0.75 HPRT1 (0.47) KIF11CDK4CCND1BCL2L1BAD
SCHEMBL27528878 0.75 BCL2L1 (0.48) KIF11CDK4CCND1BCL2L1BAD
SCHEMBL27584193 0.74 GNG2 (0.47) KIF11CDK4CCND1BCL2L1BAD
SCHEMBL28118478 0.73 KIF11 (0.45) KIF11NPC1CDK4CCND1BCL2L1
Ethane SCHEMBL27403615 0.71 HPRT1 (0.50) KIF11TSHRHTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108440614-A The inhibitor of sodium glucose cotransporter 1 莱西肯医药有限公司 2018-08-24 — — CN disclosed
Send feedback